| 000 | 01858 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513222825.0 | ||
| 264 | 0 | _c20001130 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1702607 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReece, D E | |
| 245 | 0 | 0 |
_aUse of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cOct 2000 |
||
| 300 |
_a729-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _ximmunology |
| 650 | 0 | 4 |
_aBone Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aBreast Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aLiver Neoplasms _ximmunology |
| 650 | 0 | 4 |
_aLymphatic Metastasis _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFoon, K A | |
| 700 | 1 | _aBhattacharya-Chatterjee, M | |
| 700 | 1 | _aHale, G A | |
| 700 | 1 | _aHoward, D S | |
| 700 | 1 | _aMunn, R K | |
| 700 | 1 | _aNath, R | |
| 700 | 1 | _aPlummer, B A | |
| 700 | 1 | _aTeitelbaum, A | |
| 700 | 1 | _aPhillips, G L | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 26 _gno. 7 _gp. 729-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1702607 _zAvailable from publisher's website |
| 999 |
_c10987648 _d10987648 |
||